176 related articles for article (PubMed ID: 35303068)
1. Comparing survival between neoadjuvant chemoradiotherapy followed by open or thoracoscopic oesophagectomy in patients with oesophageal squamous cell carcinoma.
Chen HS; Lin CH; Wu SC; Wang BY
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35303068
[TBL] [Abstract][Full Text] [Related]
2. Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients With Esophageal Squamous Cell Carcinoma.
Wang BY; Lin CH; Wu SC; Chen HS
Ann Surg; 2023 Jan; 277(1):e53-e60. PubMed ID: 34117148
[TBL] [Abstract][Full Text] [Related]
3. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma.
Chen HS; Lin CH; Wu SC; Wang BY
Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
[TBL] [Abstract][Full Text] [Related]
5. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS
Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted versus thoracolaparoscopic oesophagectomy for locally advanced oesophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Jiang H; Guo X; Sun Y; Hua R; Li B; Li Z
Eur J Surg Oncol; 2023 Apr; 49(4):832-837. PubMed ID: 36470800
[TBL] [Abstract][Full Text] [Related]
7. Concurrent radiotherapy cannot provide superiority of surgical oncological outcome and long-term survival rate in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
Wang YJ; Bao T; Li KK; Xie XF; He XD; Zhao XL; Guo W
Surg Endosc; 2023 Sep; 37(9):7073-7082. PubMed ID: 37380741
[TBL] [Abstract][Full Text] [Related]
8. Safety and Feasibility of Esophagectomy Following Combined Immunotherapy and Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Analysis.
Hong ZN; Gao L; Weng K; Huang Z; Han W; Kang M
Front Immunol; 2022; 13():836338. PubMed ID: 35300335
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study.
Kamarajah SK; Phillips AW; Ferri L; Hofstetter WL; Markar SR
Br J Surg; 2021 Apr; 108(4):403-411. PubMed ID: 33755097
[TBL] [Abstract][Full Text] [Related]
11. Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Chang YL; Cheng YF; Chen HS; Wu SC; Hung WH; Chen HC; Huang CL; Cheng CY; Wang BY
PLoS One; 2022; 17(10):e0271338. PubMed ID: 36227954
[TBL] [Abstract][Full Text] [Related]
12. The comparisons of neoadjuvant chemoimmunotherapy versus chemoradiotherapy for oesophageal squamous cancer.
Xiao X; Yang YS; Zeng XX; Shang QX; Luan SY; Zhou JF; Li XK; Fang PH; Hu Y; Chen LQ; Yuan Y
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35695773
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive versus open oesophagectomy for cancer: propensity score analysis improves results' reliability but matching criteria need to be selected accurately.
Giulini L; Dubecz A
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35349668
[No Abstract] [Full Text] [Related]
15. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma.
Hsu PK; Chen HS; Liu CC; Wu SC
Ann Surg Oncol; 2019 Feb; 26(2):506-513. PubMed ID: 30430325
[TBL] [Abstract][Full Text] [Related]
16. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random.
Qian D; Chen X; Shang X; Wang Y; Tang P; Han D; Jiang H; Chen C; Zhao G; Zhou D; Cao F; Er P; Zhang W; Li X; Zhang T; Zhang B; Guan Y; Wang J; Yuan Z; Yu Z; Wang P; Pang Q
Radiother Oncol; 2022 Sep; 174():1-7. PubMed ID: 35764191
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term outcomes of thoracoscopic esophagectomy in the prone position for esophageal squamous cell carcinoma in patients with obstructive ventilatory disorder: a propensity score-matched study.
Goto H; Oshikiri T; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
Surg Endosc; 2022 Dec; 36(12):8834-8842. PubMed ID: 35546208
[TBL] [Abstract][Full Text] [Related]
18. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J
JAMA Surg; 2021 Aug; 156(8):721-729. PubMed ID: 34160577
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy.
Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Ohsawa M; Kitasaki N; Okada M
Anticancer Res; 2021 Jun; 41(6):3011-3021. PubMed ID: 34083292
[TBL] [Abstract][Full Text] [Related]
20. Propensity-Matched Analysis Comparing Survival After Hybrid Thoracoscopic-Laparotomy Esophagectomy and Complete Thoracoscopic-Laparoscopic Esophagectomy.
Li KK; Wang YJ; Liu XH; Wang RW; Jiang YG; Guo W
World J Surg; 2019 Mar; 43(3):853-861. PubMed ID: 30386913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
